What is the Falsified Medicines Directive?
On 9th February 2019, the European Union Falsified Medicines Directive (EU FMD) will come into force. The Directive introduces measures to combat falsified medicines.
These measures will comprise of an Anti-tamper device, and a 2D Matrix barcode which dispensers will need to scan to verify their authenticity before dispensing to patients.
What to do if you have received an alert when attempting to decommission a GSK product
GSK receives information of all alerts related to GSK products centrally and investigates these within 3 working days to determine whether the issue was caused by GSK. If this is the case GSK will rectify the problem centrally if possible. We advise Health Care Professionals to re-scan after 3 working days to determine if the problem is solved. If not, then to contact their wholesaler from whom they purchased the pack.
We have provided this PDF guide to support you with FMD alert management on GSK products
If you suspect that you or one of your patients has used a counterfeit medicine and has experienced an adverse event, please use the ‘Report an Adverse Event’ button above.
- SecureMed is the not for profit company set up to establish the UK Medicines Verification System.
- National Pharmacy Association provide guidance for FMD readiness and other useful information.
- FMD Source provides UK community pharmacies with authoritative and reliable information on how to implement FMD.
- Pharmaceutical Services Negotiating Committee information regarding FMD
- EU Legislation for FMD can be found on the European Commission website.
- UK Gov provides guidance and useful resources for implementing and compliance with FMD.